BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 31105135)

  • 1. [Arenavirus research and antiviral candidate].
    Tani H; Shuzo U
    Uirusu; 2018; 68(1):51-62. PubMed ID: 31105135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arenavirus infections].
    Tani H; Fukushi S; Yoshikawa T; Saijo M; Morikawa S
    Uirusu; 2012; 62(2):229-38. PubMed ID: 24153233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zoonotic aspects of arenavirus infections.
    Charrel RN; de Lamballerie X
    Vet Microbiol; 2010 Jan; 140(3-4):213-20. PubMed ID: 19748747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arenavirus Quasispecies and Their Biological Implications.
    Grande-Pérez A; Martin V; Moreno H; de la Torre JC
    Curr Top Microbiol Immunol; 2016; 392():231-76. PubMed ID: 26472215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research efforts to control highly pathogenic arenaviruses: a summary of the progress and gaps.
    Kerber R; Reindl S; Romanowski V; Gómez RM; Ogbaini-Emovon E; Günther S; ter Meulen J
    J Clin Virol; 2015 Mar; 64():120-7. PubMed ID: 25549822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and cell biology of the prototypic arenavirus LCMV: implications for understanding and combating hemorrhagic fever arenaviruses.
    de la Torre JC
    Ann N Y Acad Sci; 2009 Sep; 1171 Suppl 1():E57-64. PubMed ID: 19751403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reverse genetics approaches to combat pathogenic arenaviruses.
    de la Torre JC
    Antiviral Res; 2008 Dec; 80(3):239-50. PubMed ID: 18782590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel drug discovery approaches for treating arenavirus infections.
    Pasquato A; Kunz S
    Expert Opin Drug Discov; 2016; 11(4):383-93. PubMed ID: 26882218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arenaviruses and hantaviruses: from epidemiology and genomics to antivirals.
    Charrel RN; Coutard B; Baronti C; Canard B; Nougairede A; Frangeul A; Morin B; Jamal S; Schmidt CL; Hilgenfeld R; Klempa B; de Lamballerie X
    Antiviral Res; 2011 May; 90(2):102-14. PubMed ID: 21356244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel antiviral strategies to combat human Arenavirus infections.
    Kunz S; de la Torre JC
    Curr Mol Med; 2005 Dec; 5(8):735-51. PubMed ID: 16375709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mining a Kröhnke Pyridine Library for Anti-Arenavirus Activity.
    Miranda PO; Cubitt B; Jacob NT; Janda KD; de la Torre JC
    ACS Infect Dis; 2018 May; 4(5):815-824. PubMed ID: 29405696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arenaviruses other than Lassa virus.
    Charrel RN; de Lamballerie X
    Antiviral Res; 2003 Jan; 57(1-2):89-100. PubMed ID: 12615305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique small molecule entry inhibitors of hemorrhagic fever arenaviruses.
    Lee AM; Rojek JM; Spiropoulou CF; Gundersen AT; Jin W; Shaginian A; York J; Nunberg JH; Boger DL; Oldstone MB; Kunz S
    J Biol Chem; 2008 Jul; 283(27):18734-42. PubMed ID: 18474596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel strategies for development of hemorrhagic fever arenavirus live-attenuated vaccines.
    Martinez-Sobrido L; de la Torre JC
    Expert Rev Vaccines; 2016 Sep; 15(9):1113-21. PubMed ID: 27118328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arenavirus extinction through lethal mutagenesis.
    de la Torre JC
    Virus Res; 2005 Feb; 107(2):207-14. PubMed ID: 15649566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of peptide-conjugated morpholino oligomers as pan-arenavirus inhibitors.
    Neuman BW; Bederka LH; Stein DA; Ting JP; Moulton HM; Buchmeier MJ
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4631-8. PubMed ID: 21825302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
    Torriani G; Trofimenko E; Mayor J; Fedeli C; Moreno H; Michel S; Heulot M; Chevalier N; Zimmer G; Shrestha N; Plattet P; Engler O; Rothenberger S; Widmann C; Kunz S
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the vascular endothelium in arenavirus haemorrhagic fevers.
    Kunz S
    Thromb Haemost; 2009 Dec; 102(6):1024-9. PubMed ID: 19967131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and patient management of Lujo hemorrhagic fever.
    Sewlall NH; Richards G; Duse A; Swanepoel R; Paweska J; Blumberg L; Dinh TH; Bausch D
    PLoS Negl Trop Dis; 2014; 8(11):e3233. PubMed ID: 25393244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of live-attenuated arenavirus vaccines based on codon deoptimization.
    Cheng BY; Ortiz-Riaño E; Nogales A; de la Torre JC; Martínez-Sobrido L
    J Virol; 2015 Apr; 89(7):3523-33. PubMed ID: 25589652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.